The primary benefit of IL-2 therapy is its ability to induce long-term remission in some cancer patients. For certain individuals, IL-2 can lead to a complete response where the cancer is no longer detectable. This potential for durable remission is a significant advantage over other therapies that may only provide temporary relief.
